S&P Futures
4,166.00 +35.50 (+0.86%) Dow Futures
34,243.00 +248.00 (+0.73%) Nasdaq Futures
12,697.25 +152.00 (+1.21%) Russell 2000 Futures
1,966.00 +16.10 (+0.83%) Crude Oil
78.78 +0.31 (+0.40%) Gold
1,896.70 +6.00 (+0.32%)
Taysha Gene Therapies, Inc. (TSHA)
Pre-Market:
Chart Events
Performance Outlook
| Previous Close | 1.1600 |
| Open | 1.1500 |
| Bid | 0.0000 x 1000 |
| Ask | 0.0000 x 800 |
| Day's Range | 1.1200 - 1.1900 |
| 52 Week Range | 1.0600 - 8.1400 |
| Volume | |
| Avg. Volume | 729,053 |
| Market Cap | 70.56M |
| Beta (5Y Monthly) | 1.40 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -3.8080 |
| Earnings Date | Mar 29, 2023 - Apr 03, 2023 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 22.08 |
- Simply Wall St.
A Taysha Gene Therapies, Inc. (NASDAQ:TSHA) insider increased their holdings by 28% last year
Viewing insider transactions for Taysha Gene Therapies, Inc.'s ( NASDAQ:TSHA ) over the last year, we see that insiders...
- GlobeNewswire
Taysha Gene Therapies Provides Update on TSHA-120 Program in Giant Axonal Neuropathy and a 2023 Corporate Outlook
Type B end-of-Phase 2 meeting with U.S. Food and Drug Administration (FDA) provided additional clarity for TSHA-120 for the treatment of giant axonal neuropathy (GAN) ultra-rare disease program - FDA acknowledged MFM32 as an acceptable endpoint with a recommendation to dose additional patients in a double-blind, placebo-controlled design to support Biologics License Application (BLA) submission Organizational and business review by new management with operational, structural and personnel change
- American City Business Journals
Biotech signals potential pullback from 200-job Durham plant
State officials have terminated an incentive agreement for a Texas-based biotech that had planned to invest $75 million in a manufacturing facility in Durham. The state's Economic Investment Committee, part of the North Carolina Department of Commerce, voted unanimously Tuesday to terminate a package awarded to Taysha Gene Therapies (Nasdaq: TSHA) in late 2020. The vote was in response to a letter the department received from the company requesting withdrawal from the state's Job Development Investment Grant program.
